Treatment of idiopathic pulmonary fibrosis;Le traitement des fibroses pulmonaires idiopathiques

Revue des Maladies Respiratoires

Volumn 23, Issue 2 C2, 2006, Pages

  Dury, S ^a,b  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BETA INTERFERON; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ETANERCEPT; GAMMA INTERFERON; GLUTATHIONE; ISONIAZID; PREDNISOLONE;

ANTIMICROBIAL THERAPY; ARTICLE; CORTICOSTEROID THERAPY; DRUG INDICATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LUNG FIBROSIS; LUNG TUBERCULOSIS; PATHOPHYSIOLOGY; PNEUMOCYSTIS PNEUMONIA; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DRUG COMBINATIONS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; PREDNISONE; PULMONARY FIBROSIS; TREATMENT OUTCOME;

EID: 33745453175     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG : Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978 ; 298 : 801-9.
2. Bouros D, Antoniou KM : Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur Respir J 2005 ; 26 : 693-703.
3. Richeldi L, Davies HR, Ferrarra G, Franco F : Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev 2003 ; 3 : CD002880.
4. Flaherty KR, Toews GB, Lynch JP, Kazerooni EA, Gross RL, Strawderman BH, Hariharah K, Flint A, Martinez FJ : Steroids in idiopathic pulmonary fibrosis: a propective assessment of adverse reactions, response to therapy, and survival. Am J Med 2001 ; 110 : 278-82.
5. Gay SE, Kazerooni EA, Toews GB, Lynch III JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ : Idiopathic pulmonary fibrosis. Predicting response to therapy and survival. Am J Respir Crit Care Med 1998 ; 157 : 1063-72.
6. Raghu G, Desapo WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, Hutchinson J, Pardee NE, Winterbauer RH : Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991 ; 144 : 292-6.
7. Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE, Brown KK : Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest 2004 ; 125 : 2169-74.
8. Joint statement of the American Thoracic Society and the European Respiratory Society : Idiopathic Pulmonary Fibrosis : diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000 ; 161 : 646-64.
9. Crestani B, Marchand-Adam S, Schneider S : Traitements médicamenteux de la fibrose pulmonaire idiopathique. Rev Pneumol Clin 2005 ; 61 : 221-31.
10. Costabel U, King TE : International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J 2001 ; 17 : 163-7.
11. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE, Flaherty KR, Schwartz DA, Noble PW, Raghu G, Brown KK, IPF Group Study : The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005 ; 142 : 963-7.
12. De Vries J., Kessels B.L.J. , M. Drent. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 2001 ; 17 : 954-61.
13. American Thoracic Society : International guidelines for the selection of lung transplant candidates. Am J respir Crit Care Med 1998 ; 158 : 335-9.
14. Nathan SD : Lung transplantation. Disease-specific considerations for referral. Chest 2005 ; 127 : 1006-16.
15. Martinez FJ : Idiopathic interstitial pneumonias. Usual interstitial Pneumonia versus nonspecific interstitial pneumonia. Proc Am Thorac Soc 2006 ; 3 : 81-95.
16. Selman M, King TE, Pardo A : Idiopathic pulmonary fibrosis: prevailing and evolution hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001 ; 134 : 136-51.
17. King TE, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA, Flint A, Thurlbeck WJ Cherniack RM : Idiopathic pulmonary fibrosis. Relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001 ; 164 : 1025-32.
18. Demets M, et members of the IFIGENIA study group : High-dose acethylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005 ; 353 : 2229-42.
19. Douglas WW, Ryu JH, Schroeder DR : Idiopathic pulmonary fibrosis. Impact of oxygen and colchicines, prednisone, or no therapy on survival. Am J Respir Crit Care Med 2000 ; 161 : 1172-8.
20. Selman M, Carillo G, Salas J, Padilla RP, Perez-Chavira R, Sansores R, Chapela R : Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis. A controlled clinical trial. Chest 1998 ; 114 : 507-12.
21. Douglas WW, Ryu JH, Swensen SJ, Offord KP, Schroeder DR, Caron GM, DeRemee RA, and members of the lung study group : Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998 ; 158 : 220-5.
22. Raghu G, Johnson WC, Lockhart D, Mageto Y : Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone. Results of a prospective, open-label phase II study. Am J Respir Crit Care Med 1999 ; 159 : 1061-9.
23. Azuma et members of the research group for diffuse lung diseases in japan, G. Raghu. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005 ; 171 : 1040-7.
24. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH : A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999 ; 341 : 1264-9.
25. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwarz DA, King TE : A placebo-controled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004 ; 350 : 125-33.
26. Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, Schwarz MI, Cool CD, Worthen GS : Pigment epithelium-derived factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004 ; 170 : 242-51.